86 related articles for article (PubMed ID: 1601065)
1. The calcium channel antagonist, flunarizine, protects against ventricular fibrillation.
Billman GE
Eur J Pharmacol; 1992 Mar; 212(2-3):231-5. PubMed ID: 1601065
[TBL] [Abstract][Full Text] [Related]
2. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
Billman GE
J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569
[TBL] [Abstract][Full Text] [Related]
3. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs.
Billman GE; Avendano CE; Halliwill JR; Burroughs JM
J Cardiovasc Pharmacol; 1993 Feb; 21(2):197-204. PubMed ID: 7679152
[TBL] [Abstract][Full Text] [Related]
4. Intracellular calcium chelator, BAPTA-AM, prevents cocaine-induced ventricular fibrillation.
Billman GE
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1529-35. PubMed ID: 8238564
[TBL] [Abstract][Full Text] [Related]
5. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
Billman GE
J Pharmacol Exp Ther; 1994 Apr; 269(1):409-16. PubMed ID: 7909562
[TBL] [Abstract][Full Text] [Related]
6. Effect of carbachol and cyclic GMP on susceptibility to ventricular fibrillation.
Billman GE
FASEB J; 1990 Apr; 4(6):1668-73. PubMed ID: 2156744
[TBL] [Abstract][Full Text] [Related]
7. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Billman GE
Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
[TBL] [Abstract][Full Text] [Related]
8. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs.
Billman GE; Englert HC; Schölkens BA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1465-73. PubMed ID: 9732412
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha 1-adrenergic receptor antagonists on susceptibility to malignant arrhythmias: protection from ventricular fibrillation.
Billman GE
J Cardiovasc Pharmacol; 1994 Sep; 24(3):394-402. PubMed ID: 7528295
[TBL] [Abstract][Full Text] [Related]
10. Effect of ryanodine on ventricular fibrillation induced by myocardial ischaemia.
Lappi MD; Billman GE
Cardiovasc Res; 1993 Dec; 27(12):2152-9. PubMed ID: 8313422
[TBL] [Abstract][Full Text] [Related]
11. Cocaine-induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil.
Billman GE; Hoskins RS
FASEB J; 1988 Nov; 2(14):2990-5. PubMed ID: 3181653
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death.
Billman GE; Castillo LC; Hensley J; Hohl CM; Altschuld RA
Circulation; 1997 Sep; 96(6):1914-22. PubMed ID: 9323081
[TBL] [Abstract][Full Text] [Related]
13. K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity.
Vanoli E; Hull SS; Adamson PB; Foreman RD; Schwartz PJ
J Cardiovasc Pharmacol; 1995 Dec; 26(6):847-54. PubMed ID: 8606519
[TBL] [Abstract][Full Text] [Related]
14. Prevention of ventricular fibrillation with magnesium sulfate.
Billman GE; Hoskins RS
Eur J Pharmacol; 1988 Dec; 158(1-2):167-71. PubMed ID: 3220116
[TBL] [Abstract][Full Text] [Related]
15. Elevated myocardial calcium and its role in sudden cardiac death.
Billman GE; McIlroy B; Johnson JD
FASEB J; 1991 Aug; 5(11):2586-92. PubMed ID: 1714409
[TBL] [Abstract][Full Text] [Related]
16. Effect of flunarizine on defibrillation outcomes and early refibrillation in a canine model of prolonged ventricular fibrillation.
Xing C; Jin Q; Zhang N; Liu S; Lin C; Wu Q; Luo Q; Liu A; Wu L
Exp Physiol; 2019 Nov; 104(11):1630-1637. PubMed ID: 31465138
[TBL] [Abstract][Full Text] [Related]
17. Effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation.
Billman GE
J Pharmacol Exp Ther; 1989 Mar; 248(3):1334-42. PubMed ID: 2467981
[TBL] [Abstract][Full Text] [Related]
18. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
[TBL] [Abstract][Full Text] [Related]
19. Effects of endurance exercise training on heart rate variability and susceptibility to sudden cardiac death: protection is not due to enhanced cardiac vagal regulation.
Billman GE; Kukielka M
J Appl Physiol (1985); 2006 Mar; 100(3):896-906. PubMed ID: 16322370
[TBL] [Abstract][Full Text] [Related]
20. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
